Showing results (251-260 of 306) with videos related to

Sort By:
Pageof 31
European Radiology|November 14, 2018
Quantitative 3-T multi-parametric MRI and step-section pathology of recurrent prostate cancer patients after radiation therapyCatarina Dinis Fernandes, Ghazaleh Ghobadi, Henk G van der Poel, et al.
Medical Physics|January 1, 2017
Multicenter validation of prostate tumor localization using multiparametric MRI and prior knowledgeCuong Viet Dinh, Peter Steenbergen, Ghazaleh Ghobadi, et al.
European Radiology|July 10, 2026
Deep learning-based malignancy probability estimation of pulmonary nodules in PET/CT imagingLars Leijten, Erik H J G Aarntzen, Roel L J Verhoeven, et al.
Frontiers in Oncology|December 24, 2019
Quantitative MRI Changes During Weekly Ultra-Hypofractionated Prostate Cancer Radiotherapy With Integrated BoostMarcel A van Schie, Petra J van Houdt, Ghazaleh Ghobadi, et al.
Physics in Medicine and Biology|May 31, 2017
Repeatability of dose painting by numbers treatment planning in prostate cancer radiotherapy based on multiparametric magnetic resonance imagingMarcel A van Schie, Peter Steenbergen, Cuong Viet Dinh, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 8, 2018
Contouring of prostate tumors on multiparametric MRI: Evaluation of clinical delineations in a multicenter radiotherapy trialMarcel A van Schie, Cuong V Dinh, Petra J van Houdt, et al.
BMJ Open|May 7, 2026
Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trialSian Cooper, Sophie Alexander, Dylan Breitkreutz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2023
From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trialLisa De Cock, Cédric Draulans, Floris J Pos, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 30, 2025
Understanding national Societies' needs and enhancing collaboration with ESTRO: A report of the national Societies survey 2024, on behalf of the ESTRO national Societies committeeBanu Atalar, Federico Mastroleo, Mattia Zaffaroni, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2025
Primary Endpoint Analysis of the Phase 2 DESTINATION-MRL Trial for Patients With Intermediate-Risk Prostate CancerMathijs G Dassen, Alison C Tree, Lisa Wiersema, et al.
Pageof 31